HUTCHMED (China) Ltd (HCM): Depreciation & Amortization
$13.31M
Year ended 2025-12-31
+15.4%
3-year compound annual growth
+17.0%
5-year compound annual growth
+20.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.31M | +7.8% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $12.34M | +50.4% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $8.21M | -5.3% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $8.66M | +20.5% | 2025-03-19, From 2022-01-01 |
| 2021-12-31 | $7.19M | +18.6% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $6.06M | +22.6% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $4.94M | +37.7% | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | $3.59M | +39.3% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $2.58M | +10.1% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $2.34M | +16.2% | 2019-03-11, From 2016-01-01 |
| 2015-12-31 | $2.02M | +59.3% | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | $1.26M | n/a | 2017-03-13, From 2014-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
Compare HCM, ORGO, MIRM, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗